[DOI] [PubMed] [Google Scholar] 295.Takahashi, R
Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
For most local injection-site reactions redness, itching, or mild swelling that clears within a few days you can keep injecting on schedule
By targeting both GLP-1 and GIP receptors, Tirzepatide offers a dual-action approach that can lead to greater weight loss compared to other medications, while also helping manage cravings and portion control
